Plan B “Not Approvable” Decision Puts FDA, CDER Director In Hot Seat
Executive Summary
FDA's "not approvable" decision for Barr Labs' emergency contraceptive Plan B over-the-counter switch puts the agency back in the spotlight of presidential campaign politics